α-galactosylceramide (α-GalCer) (including allogeneic sources), a specific ligand of invariant natural killer T (iNKT) cells, exerts an anti-tumor effect by increasing production of the tumor growth suppressor IFN-γ (Hasegawa et al., 2014). This evidence concerns the gene IFNG and neoplasm.